Global Long Acting Drug Delivery Market Research Report 2022

Table Of Contents

1 Report Overview

1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Long Acting Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Device 1.2.3 Parenteral Injections 1.3 Market by Application 1.3.1 Global Long Acting Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Specialty Clinics 1.3.4 Clinical Research Institutes 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered2 Global Growth Trends 2.1 Global Long Acting Drug Delivery Market Perspective (2017-2028) 2.2 Long Acting Drug Delivery Growth Trends by Region 2.2.1 Long Acting Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Long Acting Drug Delivery Historic Market Size by Region (2017-2022) 2.2.3 Long Acting Drug Delivery Forecasted Market Size by Region (2023-2028) 2.3 Long Acting Drug Delivery Market Dynamics 2.3.1 Long Acting Drug Delivery Industry Trends 2.3.2 Long Acting Drug Delivery Market Drivers 2.3.3 Long Acting Drug Delivery Market Challenges 2.3.4 Long Acting Drug Delivery Market Restraints3 Competition Landscape by Key Players 3.1 Global Top Long Acting Drug Delivery Players by Revenue 3.1.1 Global Top Long Acting Drug Delivery Players by Revenue (2017-2022) 3.1.2 Global Long Acting Drug Delivery Revenue Market Share by Players (2017-2022) 3.2 Global Long Acting Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Long Acting Drug Delivery Revenue 3.4 Global Long Acting Drug Delivery Market Concentration Ratio 3.4.1 Global Long Acting Drug Delivery Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Long Acting Drug Delivery Revenue in 2021 3.5 Long Acting Drug Delivery Key Players Head office and Area Served 3.6 Key Players Long Acting Drug Delivery Product Solution and Service 3.7 Date of Enter into Long Acting Drug Delivery Market 3.8 Mergers & Acquisitions, Expansion Plans4 Long Acting Drug Delivery Breakdown Data by Type 4.1 Global Long Acting Drug Delivery Historic Market Size by Type (2017-2022) 4.2 Global Long Acting Drug Delivery Forecasted Market Size by Type (2023-2028)5 Long Acting Drug Delivery Breakdown Data by Application 5.1 Global Long Acting Drug Delivery Historic Market Size by Application (2017-2022) 5.2 Global Long Acting Drug Delivery Forecasted Market Size by Application (2023-2028)6 North America 6.1 North America Long Acting Drug Delivery Market Size (2017-2028) 6.2 North America Long Acting Drug Delivery Market Size by Country (2017-2022) 6.3 North America Long Acting Drug Delivery Market Size by Country (2023-2028) 6.4 United States 6.5 Canada7 Europe 7.1 Europe Long Acting Drug Delivery Market Size (2017-2028) 7.2 Europe Long Acting Drug Delivery Market Size by Country (2017-2022) 7.3 Europe Long Acting Drug Delivery Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries8 Asia-Pacific 8.1 Asia-Pacific Long Acting Drug Delivery Market Size (2017-2028) 8.2 Asia-Pacific Long Acting Drug Delivery Market Size by Country (2017-2022) 8.3 Asia-Pacific Long Acting Drug Delivery Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia9 Latin America 9.1 Latin America Long Acting Drug Delivery Market Size (2017-2028) 9.2 Latin America Long Acting Drug Delivery Market Size by Country (2017-2022) 9.3 Latin America Long Acting Drug Delivery Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil10 Middle East & Africa 10.1 Middle East & Africa Long Acting Drug Delivery Market Size (2017-2028) 10.2 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2017-2022) 10.3 Middle East & Africa Long Acting Drug Delivery Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE11 Key Players Profiles 11.1 ViiV Healthcare 11.1.1 ViiV Healthcare Company Detail 11.1.2 ViiV Healthcare Business Overview 11.1.3 ViiV Healthcare Long Acting Drug Delivery Introduction 11.1.4 ViiV Healthcare Revenue in Long Acting Drug Delivery Business (2017-2022) 11.1.5 ViiV Healthcare Recent Development 11.2 Halozyme Therapeutics 11.2.1 Halozyme Therapeutics Company Detail 11.2.2 Halozyme Therapeutics Business Overview 11.2.3 Halozyme Therapeutics Long Acting Drug Delivery Introduction 11.2.4 Halozyme Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022) 11.2.5 Halozyme Therapeutics Recent Development 11.3 Lubrizol Life Science 11.3.1 Lubrizol Life Science Company Detail 11.3.2 Lubrizol Life Science Business Overview 11.3.3 Lubrizol Life Science Long Acting Drug Delivery Introduction 11.3.4 Lubrizol Life Science Revenue in Long Acting Drug Delivery Business (2017-2022) 11.3.5 Lubrizol Life Science Recent Development 11.4 Celanese Corporation 11.4.1 Celanese Corporation Company Detail 11.4.2 Celanese Corporation Business Overview 11.4.3 Celanese Corporation Long Acting Drug Delivery Introduction 11.4.4 Celanese Corporation Revenue in Long Acting Drug Delivery Business (2017-2022) 11.4.5 Celanese Corporation Recent Development 11.5 Kashiv BioSciences 11.5.1 Kashiv BioSciences Company Detail 11.5.2 Kashiv BioSciences Business Overview 11.5.3 Kashiv BioSciences Long Acting Drug Delivery Introduction 11.5.4 Kashiv BioSciences Revenue in Long Acting Drug Delivery Business (2017-2022) 11.5.5 Kashiv BioSciences Recent Development 11.6 4P Therapeutics 11.6.1 4P Therapeutics Company Detail 11.6.2 4P Therapeutics Business Overview 11.6.3 4P Therapeutics Long Acting Drug Delivery Introduction 11.6.4 4P Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022) 11.6.5 4P Therapeutics Recent Development 11.7 Ipsen 11.7.1 Ipsen Company Detail 11.7.2 Ipsen Business Overview 11.7.3 Ipsen Long Acting Drug Delivery Introduction 11.7.4 Ipsen Revenue in Long Acting Drug Delivery Business (2017-2022) 11.7.5 Ipsen Recent Development 11.8 Midatech Pharma 11.8.1 Midatech Pharma Company Detail 11.8.2 Midatech Pharma Business Overview 11.8.3 Midatech Pharma Long Acting Drug Delivery Introduction 11.8.4 Midatech Pharma Revenue in Long Acting Drug Delivery Business (2017-2022) 11.8.5 Midatech Pharma Recent Development 11.9 Re-Vana Therapeutics 11.9.1 Re-Vana Therapeutics Company Detail 11.9.2 Re-Vana Therapeutics Business Overview 11.9.3 Re-Vana Therapeutics Long Acting Drug Delivery Introduction 11.9.4 Re-Vana Therapeutics Revenue in Long Acting Drug Delivery Business (2017-2022) 11.9.5 Re-Vana Therapeutics Recent Development 11.10 Creative Biolabs 11.10.1 Creative Biolabs Company Detail 11.10.2 Creative Biolabs Business Overview 11.10.3 Creative Biolabs Long Acting Drug Delivery Introduction 11.10.4 Creative Biolabs Revenue in Long Acting Drug Delivery Business (2017-2022) 11.10.5 Creative Biolabs Recent Development12 Analyst's Viewpoints/Conclusions13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details